Pfizer – “Long slide down....”

Pros

The benefits and pay. At least they used to pay well before they went to all Jr. employees and offshored everything.

Cons

The company has become too large too fast. The CEO is not research-minded or knowledgeable about the business. He destroyed Boston Market, and will do the same to Pfizer. All of the Sr. staff is being sent out the door to cut costs, and much of the initial research industrywide is being done abroad and in the East - with many errors.

Advice to Senior Management

Put scientists back at the helm. Stop cutting costs to pad your pockets. This is an expensive business. Spend the money to do it right, or go home and let someone else do it better.